| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.2B | $15.7B | $13.4B | $12.5B | $12.2B | $11.1B | $2.9B | $2.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.3B | $3.8B | $3.8B | $3.7B | $2.1B | $2.8B | $0.5B | $0.5B |
| Net Income | $3.7B | $2.7B | $2.6B | $2.6B | $1.3B | $2.0B | $0.4B | $0.4B |
| EPS (Basic) | $17.11 | $12.55 | $12.60 | $12.23 | $5.59 | $8.49 | $1.59 | $1.42 |
| EPS (Diluted) | $17.02 | $12.49 | $12.51 | $12.14 | $5.55 | $8.45 | $1.58 | $1.41 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $50.8B | $49.0B | $34.0B | $32.7B | $31.9B | $32.1B | $29.4B | $26.4B |
| Current Assets | $25.8B | $23.4B | $21.7B | $20.7B | $19.0B | $18.7B | $16.5B | $14.4B |
| Cash & Equivalents | $1.2B | $1.1B | $0.8B | $0.7B | $0.5B | $0.9B | $0.8B | $0.7B |
| Total Liabilities | $41.2B | $42.5B | $34.7B | $33.1B | $30.8B | $28.5B | $26.0B | $22.2B |
| Current Liabilities | $23.2B | $23.0B | $21.7B | $20.3B | $19.1B | $17.4B | $15.6B | $13.3B |
| Stockholders' Equity | $9.4B | $6.1B | $-0.8B | $-0.5B | $1.1B | $3.5B | $3.4B | $4.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.5B | $3.0B | $3.4B | $3.2B | $2.2B | $2.8B | $1.8B | $1.7B |
| Investing Cash Flow | $0.3B | $-2.8B | $-0.2B | $-0.4B | $0.0B | $-0.7B | $-0.2B | $0.0B |
| Capital Expenditures | $0.3B | $0.2B | $0.3B | $0.2B | $0.1B | $0.1B | $0.2B | $0.2B |
| Financing Cash Flow | $-4.2B | $0.8B | $-2.9B | $-1.8B | $-1.9B | $-2.1B | $-1.5B | $-1.7B |